|NIH Director Selects Dr. Alan M. Krensky as NIH
Deputy Director for the Office of Portfolio Analysis and Strategic
Bethesda, Maryland — National Institutes
of Health Director Elias A. Zerhouni, M.D. announced that Alan M.
Krensky, M.D. has been selected as the first NIH Deputy Director
for the Office of Portfolio Analysis and Strategic Initiatives (OPASI).
Dr. Krensky will assume his position on July 8, 2007.
“We are extremely fortunate to have Dr. Krensky join the National
Institutes of Health,” said Dr. Zerhouni. “He will play a key leadership
role as the Office of Portfolio Analysis and Strategic Initiatives
provides an ‘incubator space’ to address critical research efforts
in cross-cutting areas of NIH priorities.”
"I am pleased and honored to join the NIH leadership team at this
most important time. OPASI will facilitate interactions across NIH
activities, including systems for portfolio analysis, new ‘roadmap’ and
trans-NIH strategic initiatives, and program evaluation. Such institutional
planning and assessment is critical as the interdisciplinary nature
of biomedical science evolves,” said Dr. Krensky.
OPASI was built on the success of the NIH Roadmap for Medical Research
and has two goals: to identify important areas of emerging scientific
opportunities or rising public health challenges, and to help accelerate
investments in these areas to make sure new ideas have a chance to
develop. OPASI provides new opportunity for more trans-NIH dialogue,
decision-making, and funding for scientific priorities and opportunities
that would be difficult to support otherwise.
Dr. Krensky graduated from the University of Pennsylvania in
1973, and received his M.D. from the University of Pennsylvania
in 1977. At the Stanford University School of Medicine, Dr. Krensky
most recently served as professor of pediatrics, Chief of the
Division of Immunology and Transplantation Biology, Associate
Chair for Research in the Department of Pediatrics, and Associate
Dean for Children’s Health.
Dr. Alan M. Krensky
Dr. Krensky’s research interests are in human cellular and
molecular immunology, transplantation immunology, and tumor
immunology. He is a member of the American Society for Clinical
Investigation and the Association of American Physicians and
is a co-author of more than 240 research papers.
Dr. Krensky has received numerous awards, including the Young
Investigator Award from the Society for Pediatric Research,
the Young Investigator Award from the American Society of Nephrology/American
Heart Association, the Joseph A. Shankman Award from the National
Kidney Foundation of Massachusetts, the Young Investigator
Award from the American Society for Histocompatibility and
Immunogenetics, the Award for Excellence in Pediatric Research
from the American Academy of Pediatrics, the Scholar in Experimental
Therapeutics Award from the Burroughs Wellcome Fund, the E.
Mead Johnson Award from the Society for Pediatric Research,
and the Novartis Established Investigator Award from the American
Society for Transplantation.
The Office of the Director, the central office at NIH,
is responsible for setting policy for NIH, which includes
27 Institutes and Centers. This involves planning, managing,
and coordinating the programs and activities of all NIH components.
The Office of the Director also includes program offices
which are responsible for stimulating specific areas of research
throughout NIH. Additional information is available at http://www.nih.gov/icd/od/.
The Office of Portfolio Analysis and Strategic Initiatives
(OPASI) provides the National Institutes of Health (NIH)
and its constituent Institutes and Centers (ICs) with the
methods and information necessary to manage their large and
complex scientific portfolios, identifies –– in concert with
multiple other inputs –– important areas of emerging scientific
opportunities or rising public health challenges, and assists
in the acceleration of investments in these areas, focusing
on those involving multiple ICs. More information about OPASI
can be found at: http://opasi.nih.gov/
The National Institutes of Health (NIH) — The Nation's
Medical Research Agency — includes 27 Institutes
and Centers and is a component of the U.S. Department of
Health and Human Services. It is the primary federal agency
for conducting and supporting basic, clinical and translational
medical research, and it investigates the causes, treatments,
and cures for both common and rare diseases. For more information
about NIH and its programs, visit www.nih.gov.